Navigation Links
Bright lights: Mystery of glowing antibody solved by Scripps research scientists
Date:2/28/2008

body.

This light-generating mechanism has rarely been observed in other luminescent proteins found in nature, Debler said. The neat thing about this system is that it acts like a molecular light switch. Neither stilbene nor the antibody themselves are notably fluorescent, but, when these two molecules combine, they yield an incredibly intense blue light.

It is the special photophysical behaviorthe extreme brightness coupled with the switch-like characterthat makes the EP2-19G2 antibody attractive as a potential biosensor and as a model for the development of other equally potent types of luminescent antibody-chromophore complexes.


'/>"/>

Contact: Mika Benedyk
mbenedyk@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related biology news :

1. Researchers set new record for brightness of quantum dots
2. Has the mystery of the Antarctic ice sheet been solved?
3. UCLA researchers solve decade-old mystery
4. Ancient mystery solved
5. ASU professor helps solve mystery of glassy water
6. 480-million-year-old fossil sheds light on 150-year-old paleontological mystery
7. Time-sharing tropical birds key to evolutionary mystery
8. Cassini on the trail of a runaway mystery
9. Magnetic snakes control fluids, gravity-defying droplets, and solving a dragonfly mystery
10. Men shed light on the mystery of human longevity, study finds
11. Folate mystery finally solved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... brain diseases such as Alzheimer,s and Parkinson,s, doctors can ... help a patient. , But they come up empty-handed ... patients with ataxia disabling disorders that rob people ... neurologists are trying to change that with the help ... Institute of Neurological Disorders and Stroke to establish a ...
(Date:12/15/2009)... at VIB and Ghent University in Flanders, Belgium have ... shock, the major cause of death in intensive care ... gas in mice with septic shock, researchers Anje Cauwels ... much less damage, while their chances of survival increased ... generally assumed that nitric oxide is responsible for the ...
(Date:12/15/2009)... available in German . , Leipzig: Species ... the future distribution of mammals. This is the finding ... indigenous European mammals. The researchers analysed data on species ... the phylogenetic information of the species. Judging by the ... species, mammals seem to adapt fast to changing climatic ...
Breaking Biology News(10 mins):UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3Septic shock: Nitric oxide beneficial after all 2Species distribution models are of only limited value for predicting future mammal distributions 2Hong Kong International Media Conference 2010 58341 1Hong Kong International Media Conference 2010 58341 2Hong Kong International Media Conference 2010 58341 3Hong Kong International Media Conference 2010 58341 4AutismOne 26amp 3B Autism Canada Present 26quot 3BCHANGING THE COURSE OF AUTISM IN CANADA 2009 26quot 3B University of Toronto 58336 1AutismOne 26amp 3B Autism Canada Present 26quot 3BCHANGING THE COURSE OF AUTISM IN CANADA 2009 26quot 3B University of Toronto 58336 2AutismOne 26amp 3B Autism Canada Present 26quot 3BCHANGING THE COURSE OF AUTISM IN CANADA 2009 26quot 3B University of Toronto 58336 3RCRC Independent Review Board Announces DHHS Research Oversight 58331 1RCRC Independent Review Board Announces DHHS Research Oversight 58331 2
... and Infectious Diseases (NIAID), part of the National ... into a large international HIV/AIDS trial comparing continuous ... levels of CD4+ cells has been stopped. Enrollment ... had twice the risk of disease progression (the ...
... human looks at a number, letter or other shape, ... respond to different components of that shape, almost instantaneously ... image that the individual then "sees" and understands, researchers ... from the university's Zanvyl Krieger Mind/Brain Institute describes the ...
... Development of a fundamentally new "candidate," or potential, vaccine ... 60,000 people annually, is reported in the current issue ... bite of infected female sand flies, visceral leishmaniasis infects ... occurring in India, Bangladesh, Nepal, Sudan and Brazil. , ...
Other Biology News:International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 2International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 3International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 4In the mind's eye: How the brain makes a whole out of parts 2Potential vaccine developed for deadly leishmaniasis disease 2Potential vaccine developed for deadly leishmaniasis disease 3
(Date:12/15/2009)... -- Reportlinker.com announces that a new market ... ,, The Future of Orphan ... Pipeline Analysis and Reimbursement ,, ... Summary ,, The author has ... Orphan Diseases Therapeutics - Market Forecasts to ...
(Date:12/15/2009)... BRIARCLIFF MANOR, N.Y., Dec. 15 The ... announced that the professional society is continuing to ... is being held in Arlington, VA, April 19-21, ... society is encouraging non-members to join the organization ... event. The submission deadline is 12 AM EST, ...
(Date:12/15/2009)... Office has announced the launch of several innovative new ... services in the current economic climate. The first ... to finance legal services over a period of 6, ... in their start-up companies. The second is aimed ... payment arrangements over 6 to 12 month period at ...
(Date:12/14/2009)... third edition of Infusion Nursing: An ... the Infusion Nurses Society (INS), includes Totect(®), the ... are a group of chemotherapy medications including daunorubicin, ... in the treatment of various types of cancer ... to the INS publication: "In September 2007, the ...
Breaking Biology Technology:Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... , , , , , ... , changed the course of modern life science research by ... and understand the crucial role of , nucleic acids in ... , Roche Applied Science recognized early-on the importance of this new technology ...
... , , , , Andrew ... David J. Harvey, University of Oxford, Oxford, UK, , ... Protein Analysis , The data presented here can be acquired ... mass spectrometers. , Introduction ,This application ...
... , , David Barnidge , Leo E. Bonilla , Gargi , ... Neuromics, Inc., Minneapolis, MN , Thermo Finnigan, San Jose, CA , , ... ICAT Analysis , , , , The data presented here ... , , , Overview , , , ...
Other Biology Technology:Advantages of Roche Applied Science amplification products 2Advantages of Roche Applied Science amplification products 3Characterization of Protein Oligosaccharides Using MSn 2Characterization of Protein Oligosaccharides Using MSn 3Characterization of Protein Oligosaccharides Using MSn 4Characterization of Protein Oligosaccharides Using MSn 5Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 2Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 3Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 4Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 5Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 6Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 7
Each Yeast-GFP clone represents an individual S. cerevisiae strain containing an open reading frame with a C-terminal Aequorea Victoria GFP (S65T) fusion tag....
... forces with the Mickle Laboratory Engineering Company ... This tissue sectioning system has been designed ... experiments and to be especially applicable to ... or from small organs. Its special features ...
Without sodium bicarbonate. Sterile, Cell culture tested...
... The Bioactive peptides are molecules of peptidic ... behaviour or activity which can be developed ... chemical and agro-food applications. In this way ... with superior properties for therapeutic applications. Primm ...
Biology Products: